Goldman Sachs Group Inc Bausch Health Companies Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,189,574 shares of BHC stock, worth $7.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,189,574
Previous 948,322
25.44%
Holding current value
$7.51 Million
Previous $6.14 Million
29.13%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BHC
# of Institutions
251Shares Held
243MCall Options Held
2.44MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$219 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$216 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$207 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$136 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$82 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.28B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...